1.A case of thanatophoric dwarfism.
Young Seuk CHOI ; Hyun Mee PARK ; Heung Gon KIM ; Chan CHOI
Korean Journal of Obstetrics and Gynecology 1991;34(9):1330-1334
No abstract available.
Thanatophoric Dysplasia*
2.Relation Among Parameters Determining the Severity of Bronchial Asthma.
Sook Young LEE ; Seung June KIM ; Seuk Chan KIM ; Soon Suk KWON ; Young Kyoon KIM ; Kwan Hyoung KIM ; Hwa Sik MOON ; Jeong Sup SONG ; Sung Hak PARK
Tuberculosis and Respiratory Diseases 2000;49(5):585-593
BACKGROUND: International consensus guidelines have recently been developed to improve the assessment and management of asthma. One of the major recommendations of these guidelines is that asthma severity should be assessed through the recognition of key symptoms, such as nocturnal waking, medication requirements, and objective measurements of lung function. Differential classification of asthma severity would lead to major differences in both long term pharmacological management and the treatment of severe exacerbation. METHODS: This study examined the relationship between the symptom score and measurements of FEV1 and PEF when expressed as a percentage of predicted values in asthmatics(n=107). RESULTS: The correlation of FEV1% with PEFR% was highly significant(r=0.83, p<0.01). However, there was agreement in terms of the classification of asthma severity in 76.6% of the paired measurements of FEV1% and PEFR%. Agreement in the classification of asthma severity was also found in 57.1% of the paired analysis of FEV1% and symptom score. 39% of the patients classified as having moderate asthma on the basis of FEV1% recording would be considered to have severe asthma if symptom score alone were used. Low baseline FEV1 and high bronchial responsiveness were associated with a low degree of perception of airway obstruction. CONCLUSION: The relationships between the symptom score, PEFR and FEV1 were generally poor. When assessing asthma severity, age, duration, PC20, and baseline FEV should be considered.
Airway Obstruction
;
Asthma*
;
Classification
;
Consensus
;
Humans
;
Lung
;
Peak Expiratory Flow Rate
3.Erratum: Addition of Author's Affiliated Institute and Correction of the Author's Name. Corrected: Safety and Immunogenicity Assessment of an Oral Cholera Vaccine through Phase I Clinical Trial in Korea.
Yeong Ok BAIK ; Seuk Keun CHOI ; Jae Woo KIM ; Jae Seung YANG ; Ick Young KIM ; Chan Wha KIM ; Jang Hee HONG
Journal of Korean Medical Science 2014;29(8):1182-1182
We found errors in our published article.
4.Erratum: Addition of Author's Affiliated Institute and Correction of the Author's Name. Corrected: Safety and Immunogenicity Assessment of an Oral Cholera Vaccine through Phase I Clinical Trial in Korea.
Yeong Ok BAIK ; Seuk Keun CHOI ; Jae Woo KIM ; Jae Seung YANG ; Ick Young KIM ; Chan Wha KIM ; Jang Hee HONG
Journal of Korean Medical Science 2014;29(8):1182-1182
We found errors in our published article.
5.Safety and Immunogenicity Assessment of an Oral Cholera Vaccine through Phase I Clinical Trial in Korea.
Young Ok BAIK ; Seuk Keun CHOI ; Jae Woo KIM ; Jae Seung YANG ; Ick Young KIM ; Chan Wha KIM ; Jang Hee HONG
Journal of Korean Medical Science 2014;29(4):494-501
The safety, tolerability and immunogenicity of an oral cholera vaccine (OCV) was assessed in adult Korean male through an open-label, non-comparative clinical study. Two doses of vaccine with an interval of 2 weeks were given to 20 healthy subjects. A total of 7 adverse events occurred in 6 subjects. However, no clinically significant change was observed in electrocardiograms, vital signs, physical examinations, and clinical laboratory tests. The immunogenicity of OCV was evaluated by serum vibriocidal assay where anti-Vibrio cholerae O1 and O139 antibodies were measured at day 0, 14, and 28 of vaccine administration. The antibody titers ranged from < 2.5-5,120 for V. cholerae O1 Inaba, < 2.5-10,240 for V. cholerae O1 Ogawa and < 2.5-480 for V. cholerae O139. In addition, the fold increase in antibody titers ranged from 1-4,096 for O1 Inaba, 1-8,192 for O1 Ogawa, and 1-384 for O139. The seroconversion rate was 95% and 45% for O1 and O139 antibodies, respectively. Our study clearly shows that administration of two doses of OCV at a 2 week-interval increases an appropriate level of antibody titer in the serum of healthy Korean adult males (Clinical Trial Number, NCT01707537).
Administration, Oral
;
Adult
;
Antibodies, Bacterial/*blood/immunology
;
Antibody Formation
;
Cholera/*prevention & control
;
Cholera Vaccines/adverse effects/*immunology
;
Creatine Kinase/blood
;
Humans
;
Male
;
Republic of Korea
;
Toothache/etiology
;
Vibrio cholerae O1/immunology
6.A Case of Clear Cell Adenocarcinoma of the Cervix Uteri and it's Diethylstillbestrol - related Maternal History.
Jang Soo KIM ; Tae Haing CHOI ; Yang Seuk HAN ; Seong Hyeok NOH ; Young Soo NOH ; Yong Mim CHOI ; Chan Yong PARK ; Eui Don LEE ; Heuni CHO
Korean Journal of Gynecologic Oncology and Colposcopy 2000;11(3):322-327
A case of vaginal and cervical adenocarcinoma, mostly of clear cell type, in young women have been associated with intrauterine exposure to diethystillbestrol(DES) or other nonsteroidal estrogenic substances and vaginal adenosis. We have encountered a case of clear-cell adenocarcinoma of the cervix uteri of 27years young house wife, in which there was a history of intrauterine exposure to DES. We presented a case with a brief review of related literature.
Adenocarcinoma
;
Adenocarcinoma, Clear Cell*
;
Cervix Uteri*
;
Estrogens
;
Female
;
Humans
;
Spouses
8.Biological Property of Recombinant Hemagglutinin-Neuraminidase Protein of Avian Paramyxovirus Type 6 Expressed by Recombinant Baculovirus.
Ji Ye KIM ; Hyun Jeong LEE ; Soo Jeong KYE ; Saeromi KIM ; Hee Jung SEUL ; Sang Eun KIM ; Hee Soo LEE ; Suk Chan JUNG ; Kang Seuk CHOI
Journal of Bacteriology and Virology 2015;45(4):319-327
Hemagglutination inhibition (HI) test employing whole virus antigen is a prescribed serological test for serotyping, diagnosis and surveillance for avian paramyxoviruses (APMVs). For use as alternative to the virus antigen, hemagglutinin-neuraminidase (HN) protein gene of the wild duck isolate APMV-6/WB12-163FS of APMV serotype 6 (APMV-6) was amplified, cloned and expressed in Spodoptera frugiperda insect cells. The HN gene of 1,842 bps in length showed nucleotide and amino acid homology of 93.4% and 97.1%, respectively with that of APMV-6 prototype strain. Putative sialic acid binding motif and potential N-linked glycosylation sites were conserved. In Western blot analysis, the expressed protein had a molecular mass of 66 kDa and reacted specifically with antiserum to APMV-6. In addition, the recombinant HN protein showed biological properties such as hemagglutination (HA) and elution. The recombinant HN protein produced from infected cells showed high HA titers (approximately 2(13) HA unit/ml). The HA activity of the recombinant HN protein was inhibited by antisera to APMV-6. In cross HA inhibition test, the recombinant HN protein had the highest titers with antisera to homologous APMV serotype, although there was weak cross reaction with some of antisera to other APMV serotypes. Our results indicated that recombinant APMV-6 HN protein would have the potential as alternative to the APMV-6 antigen in HI assays.
Avulavirus*
;
Baculoviridae*
;
Blotting, Western
;
Clone Cells
;
Cross Reactions
;
Diagnosis
;
Ducks
;
Glycosylation
;
Hemagglutination
;
HN Protein
;
Immune Sera
;
Insects
;
N-Acetylneuraminic Acid
;
Serologic Tests
;
Serotyping
;
Spodoptera
9.A Case of Autoimmune Hemolytic Anemia after Fludarabine Treatment in Waldenstrom Macroglobulinemia.
Seung Hwan MOON ; Seuk Hee CHUNG ; Dong Sik JUNG ; Chang Jae LEE ; Bong Gun SEO ; Sung Hyun KIM ; Hyuk Chan KWON ; Jae Seok KIM ; Hyo Jin KIM
Korean Journal of Hematology 2005;40(2):116-119
Waldenstrom macroglobulinemia, which is characterized by elevation of serum monoclonal IgM paraprotein, has recently been responsible for the treatment of purine analogues. Fludarabine, one of purine analogues, has been associated with autoimmune hemolytic anemia in patient with chronic lymphocytic leukemia. However, autoimmune hemolytic anemia after fludarabine treatment for Waldenstrom macroglobulinemia has not been reported. We experienced a case of autoimmune hemolytic anemia after fludarabine treatment for Waldenstrom macroglobulinemia. In this case, hemolytic anemia with positive direct Coombs' test occurred at 20 months after the first administration of fludarabine, relapsed at 5 days after re-administration. This anemia responded to steroid therapy. Autoimmune hemolytic anemia associated with fludarabine therapy can be severe and fatal, especially if a patient is re-treated with this drug after a previous episode of hemolytic anemia.
Anemia
;
Anemia, Hemolytic
;
Anemia, Hemolytic, Autoimmune*
;
Coombs Test
;
Humans
;
Immunoglobulin M
;
Leukemia, Lymphocytic, Chronic, B-Cell
;
Waldenstrom Macroglobulinemia*
10.Airway fire injury during rigid bronchoscopy in a patient with a silicon stent: A case report.
Ji Young LEE ; Chan Beom PARK ; Eun Jeong CHO ; Chang Jae KIM ; Jun Seuk CHEA ; Byung Ho LEE ; Jin Ook KIM ; Mee Young CHUNG
Korean Journal of Anesthesiology 2012;62(2):184-187
Therapeutic bronchoscopy is widely employed as an effective first-line treatment for patients with central airway obstructions. Airway fires during rigid bronchoscopy are rare, but can have potentially devastating consequences. Pulmonologist and anesthesiologist undertaking this type of procedure should be aware of this serious problem and be familiar with measures to avoid this possibly fatal complication. We report the case of a 24-year-old patient with a silicone stent who experienced an electrocautery-induced airway fire during rigid bronchoscopy.
Airway Obstruction
;
Bronchoscopy
;
Electrocoagulation
;
Fires
;
Humans
;
Mortuary Practice
;
Silicones
;
Stents
;
Young Adult